Mainz BioMed N.V. | WebDisclosure

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Home
Companies
Mainz BioMed N.V.

BRIEF

published on 07/25/2024 at 14:06, 1 year 4 months ago

Mainz Biomed lance ColoAlert amélioré pour améliorer l'efficacité du dépistage

Cancer Colorectal Mayence Biomed ColoAlerte Efficacité Du Dépistage Tampon De Stabilisation De L'ADN
PRESS RELEASE

published on 07/25/2024 at 14:01, 1 year 4 months ago

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
Mainz Biomed launches enhanced ColoAlert test with new features to improve screening efficiency and user experience. The updates aim to optimize colorectal cancer detection

ColoAlert Mainz Biomed Colorectal Cancer Screening Efficiency Enhanced Test
BRIEF

published on 07/09/2024 at 09:06, 1 year 4 months ago

Mainz Biomed Submits for FDA Breakthrough Device Designation for CRC Screening Test

Mainz Biomed Colorectal Cancer FDA Submission Breakthrough Device Screening Test
BRIEF

published on 07/09/2024 at 09:06, 1 year 4 months ago

Mainz Biomed soumet une demande de désignation de dispositif révolutionnaire par la FDA pour le test de dépistage du CRC

Cancer Colorectal Mayence Biomed Soumission À La FDA Appareil Révolutionnaire Test De Dépistage
PRESS RELEASE

published on 07/09/2024 at 09:01, 1 year 4 months ago

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
Mainz Biomed N.V. seeks FDA Breakthrough Device Designation for Next Generation CRC Screening Test with impressive clinical results

Mainz Biomed N.V. Colorectal Cancer MRNA Biomarkers FDA Breakthrough Device Designation Next Generation CRC Screening Test
BRIEF

published on 07/02/2024 at 14:06, 1 year 5 months ago

Mainz Biomed Provides Half Year 2024 Corporate Update

Diagnostic Solutions FDA Approval Mainz Biomed Colorectal Cancer Half Year Results
BRIEF

published on 07/02/2024 at 14:06, 1 year 5 months ago

Mainz Biomed fournit une mise à jour d'entreprise pour le semestre 2024

Résultats Semestriels Cancer Colorectal Mayence Biomed Approbation De La FDA Solutions De Diagnostic
PRESS RELEASE

published on 07/02/2024 at 14:01, 1 year 5 months ago

Mainz Biomed Provides Half Year 2024 Corporate Update
Mainz Biomed N.V. provides corporate update for the first half of 2024, showcasing industry-leading clinical data and strategic partnerships. Expect half-year financial results in September 2024

Strategic Partnerships Corporate Update Clinical Data Mainz Biomed N.V. Half-year Financial Results
BRIEF

published on 06/03/2024 at 14:06, 1 year 6 months ago

Mainz Biomed Unveils Industry-Leading Study Results at ASCO 2024

Mainz Biomed MRNA Biomarkers ASCO 2024 CRC Detection Multimodal Screening
BRIEF

published on 06/03/2024 at 14:06, 1 year 6 months ago

Mainz Biomed dévoile les résultats d'une étude de pointe à l'ASCO 2024

Mayence Biomed Biomarqueurs D'ARNm ASCO 2024 Détection CRC Dépistage Multimodal

Accesswire

Published on 12/05/2025 at 20:25, 16 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 26 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 51 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 21 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 56 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 43 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 15 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 26 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 49 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 55 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 23 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 23 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 30 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 30 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 43 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE